scout

Michael Cecchini, MD
Michael Cecchini, MD

Michael Cecchini, MD, is an associate professor of medicine (medical oncology) at Yale School of Medicine; as well as the co-director of the Colorectal Program in the Center for Gastrointestinal (GI) Cancers, the medical oncology section lead for the National Accreditation Program for Rectal Cancer, the co-director of the GI Clinical Research Team, and a phase 1 investigator at Yale Cancer Center

Articles by Michael Cecchini, MD

Michael Cecchini, MD

Dr Cecchini on the Results of the PROSPECT Trial in Rectal Cancer

ByMichael Cecchini, MD

Michael Cecchini, MD, discusses the phase 3 PROSPECT trial of neoadjuvant chemoradiation vs neoadjuvant fluorouracil, leucovorin, and oxaliplatin chemotherapy with selective use of chemoradiation, followed by total mesorectal excision in patients with locally advanced rectal cancer, and how this regimen may fit into the current treatment landscape for rectal cancer.

Latest Updated Articles